Phase IIIB Subcutaneous Missed Dose Study

Clinical trial NCT00533897 · COMPLETED

Trial details

NCT number: NCT00533897
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2007-11-01
Primary completion: 2008-12-01
Enrollment: 270

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.